Close Menu

NEW YORK (GenomeWeb) – Becton Dickinson reported today that preliminary estimates show fiscal first quarter revenues increased 35 percent, primarily due to the acquisition of C.R. Bard.

The firm reported preliminary revenues of $4.16 billion, compared to $3.08 billion in fiscal Q1 of 2018. On a currency-neutral basis, including revenues of Bard in both the current and past fiscal year, revenues increased 5 percent. Analysts had estimated first quarter revenues of $4.11 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.